Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
1.940
+0.150 (8.38%)
At close: Aug 13, 2025, 4:00 PM
1.911
-0.029 (-1.51%)
After-hours: Aug 13, 2025, 7:56 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $388.39 million as of August 13, 2025. Its market cap has decreased by -15.64% in one year.
Market Cap
388.39M
Enterprise Value
867.76M
1-Year Change
-15.64%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $388.39M, an increase of 90.29%. That is a compound annual growth rate of 5.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 354.80M | -18.15% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |